SG Americas Securities, LLC
- SEC CIK
- 0001313360
- Latest filing
- Aug 7, 2026
SYRE holding history
Spyre Therapeutics, Inc. in every 13F filed by SG Americas Securities, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SYRE overviewAll 13F holders of SYREFull Q2 2026 holdings
- Shares (Q2 2026)
- 12,727
- Value
- $1.13M
- % of portfolio
- <0.1%
- Quarters held
- 9
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 12,727 | $1.13M | <0.1% | −669−5.0% | Reduced | Holders |
| Q1 2026 | 13,396 | $676.0K | <0.1% | −9,947−42.6% | Reduced | Holders |
| Q4 2025 | 23,343 | $765.0K | <0.1% | +23,343 | New | Holders |
| Q2 2025 | 0 | $0 | 0.0% | −7,122−100.0% | Sold out | Holders |
| Q1 2025 | 7,122 | $115.0K | <0.1% | +7,122 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −12,589−100.0% | Sold out | Holders |
| Q3 2024 | 12,589 | $370.0K | <0.1% | +7,044+127.0% | Added | Holders |
| Q2 2024 | 5,545 | $130.0K | <0.1% | +5,545 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −17,822−100.0% | Sold out | Holders |
| Q2 2022 | 17,822 | $9.00K | <0.1% | +17,822 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −11,033−100.0% | Sold out | Holders |
| Q4 2021 | 11,033 | $52.0K | <0.1% | −17,545−61.4% | Reduced | Holders |
| Q3 2021 | 28,578 | $227.0K | <0.1% | +28,578 | New | Holders |